Insider · CIK 0001251512

FLANAGAN ROBERT J

Reports to the SEC for 4 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001251512

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+2,824 sh	—	—	22,756.318
2025-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+2,778 sh	—	—	19,638
2024-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+3,203 sh	—	—	16,713
2023-07-03	WPCW. P. Carey Inc.A Award	Director	AAward	+2,553 sh	—	—	13,510
2022-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+1,919 sh	—	—	10,957
2021-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+2,141 sh	—	—	9,038
2020-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+2,180 sh	—	—	6,897
2020-03-03	WPCW. P. Carey Inc.P Purchase	Director	PPurchase	+1,000 sh	$82.29	+$82.3K	4,717
2019-07-01	WPCW. P. Carey Inc.A Award	Director	AAward	+1,867 sh	—	—	3,717
2018-07-02	WPCW. P. Carey Inc.A Award	Director	AAward	+1,523 sh	—	—	1,850
2018-04-02	WPCW. P. Carey Inc.A Award	Director	AAward	+327 sh	—	—	327
2016-08-29	Sagent Pharmaceuticals, Inc.Stock Option to BuyD Disposition to Issuer	Director	DDisposition to Issuer	−5,103 sh	$10.15	−$51.8K	0
2016-08-29	Sagent Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−8,050 sh	$21.75	−$175K	0
2016-08-29	Sagent Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2,000 sh	$21.75	−$43.5K	0
2016-08-29	Sagent Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−434K sh	$21.75	−$9.43M	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−8,556 sh	$21.75	−$186K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−691 sh	$21.75	−$15K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,381 sh	$21.75	−$30K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,860 sh	$21.75	−$40.5K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−760 sh	$21.75	−$16.5K	0
2016-08-16	Sagent Pharmaceuticals, Inc.G Gift	Director	GGift	−4,150 sh	—	—	8,050
2016-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−230 sh	—	—	691
2016-02-25	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+460 sh	—	—	11,970
2016-02-25	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+230 sh	—	—	12,200
2016-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−460 sh	—	—	1,381
2016-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,556 sh	—	—	8,556
2016-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	11,510
2016-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	0
2016-02-21	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+760 sh	—	—	10,943
2016-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−760 sh	—	—	760
2016-02-18	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+930 sh	—	—	10,183
2016-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−930 sh	—	—	1,860
2015-04-09	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+921 sh	—	—	921
2015-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,841 sh	—	—	1,841
2015-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	9,253
2015-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	567
2015-02-21	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+760 sh	—	—	8,686
2015-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−760 sh	—	—	1,520
2015-02-18	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+930 sh	—	—	7,926
2015-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−930 sh	—	—	2,790
2014-10-22	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$31.99	−$256K	433,770
2014-10-08	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$31.96	−$256K	441,770
2014-10-07	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$31.15	−$249K	449,770
2014-09-25	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$29.72	−$238K	457,770
2014-09-24	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$30.30	−$242K	465,770
2014-09-12	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$28.25	−$226K	473,770
2014-09-11	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$28.35	−$227K	481,770
2014-08-28	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$27.07	−$217K	489,770
2014-08-27	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$27.30	−$218K	497,770
2014-08-12	Sagent Pharmaceuticals, Inc.S Sale	Director	SSale	−8,000 sh	$24.39	−$195K	505,770

Recent filings

Accepted (ET)
Jul 24
FLANAGAN ROBERT J0001025378-26-000104
SEC(opens sec.gov)
Jul 24
FLANAGAN ROBERT J0001025378-25-000108
SEC(opens sec.gov)
Jul 14
FLANAGAN ROBERT J0001025378-24-000100
SEC(opens sec.gov)
Jul 54
FLANAGAN ROBERT J0001025378-23-000091
SEC(opens sec.gov)
Jul 64
FLANAGAN ROBERT J0001025378-22-000107
SEC(opens sec.gov)
Jul 64
FLANAGAN ROBERT J0001025378-21-000082
SEC(opens sec.gov)
Jul 64
FLANAGAN ROBERT J0001025378-20-000036
SEC(opens sec.gov)
Mar 54
FLANAGAN ROBERT J0001209191-20-016702
SEC(opens sec.gov)
Jul 24
FLANAGAN ROBERT J0001209191-19-040401
SEC(opens sec.gov)
Jul 34
FLANAGAN ROBERT J0001209191-18-040799
SEC(opens sec.gov)
Apr 34
FLANAGAN ROBERT J0001209191-18-023225
SEC(opens sec.gov)
Aug 314
Sagent Pharmaceuticals, Inc.0000899243-16-028308
SEC(opens sec.gov)

Companies

Address

C/O W. P. CAREY INC. ONE MANHATTAN WEST, 395 9TH AVE, 58TH FL

NEW YORK, NY, 10001